You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tak-659

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)

Terminated
  • AML
  • AML, Adult
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Mar 15, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Marginal Zone Trial in Nagoya-shi, Chuo-ku, Seoul (TAK-659)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Follicular, Marginal Zone
  • TAK-659
  • Nagoya-shi, Aichi, Japan
  • +3 more
Aug 17, 2021

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • TAK-659
  • +5 more
  • Tucson, Arizona
  • +12 more
Dec 7, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +14 more
Aug 23, 2021

Advanced Solid Tumor and Lymphoma Malignancies Trial in Worldwide (TAK-659)

Completed
  • Advanced Solid Tumor and Lymphoma Malignancies
  • TAK-659
  • Sarasota, Florida
  • +14 more
Jul 15, 2021

Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • TAK-659
  • Birmingham, Alabama
  • +16 more
Apr 14, 2021

Diffuse Large B-cell Lymphoma Trial in Worldwide (TAK-659)

Terminated
Has Results
  • Diffuse Large B-cell Lymphoma
  • TAK-659
  • Westwood, Kansas
  • +40 more
Sep 14, 2020

Triple-Negative Breast Tumors, NSCLC, Head and Neck Carcinoma, Squamous Cell Trial in Worldwide (TAK-659, Nivolumab)

Terminated
Has Results
  • Triple-Negative Breast Neoplasms
  • +3 more
  • La Jolla, California
  • +21 more
Mar 18, 2020

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, NKTR-214)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +5 more
Jul 10, 2019

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)

Terminated
Has Results
  • Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
  • Lake Success, New York
  • +5 more
Aug 19, 2019

Advanced Solid Tumors, Lymphoma Tumors Trial ([14C]-TAK-659, TAK-659)

Withdrawn
  • Advanced Solid Neoplasms
  • Lymphoma Neoplasms
  • (no location specified)
Mar 26, 2018

Lymphoma, Malignant, Advanced Solid Tumors Trial in New Haven, Detroit, Bronx (TAK-659)

Withdrawn
  • Lymphoma, Malignant
  • Advanced Solid Neoplasms
  • TAK-659
  • New Haven, Connecticut
  • +2 more
Mar 26, 2018